Skip to main content
Top
Published in: Abdominal Radiology 10/2018

01-10-2018

Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging

Authors: Hai-lian Lyu, Jian-xia Cao, Hai-yi Wang, Zhan-bo Wang, Ming-gen Hu, Lu Ma, Ying-wei Wang, Hui-yi Ye

Published in: Abdominal Radiology | Issue 10/2018

Login to get access

Abstract

Purpose

The purpose of the study was to retrospectively analyze whether double-echo gradient-echo (GRE) chemical shift imaging (CSI) can differentiate between pancreatic metastases from clear cell renal cell carcinoma (PM-ccRCC) and pancreatic neuroendocrine tumor (pNET).

Methods

Institutional review board approval and informed consent were waived. CSI, T2WI, DWI, and DCE magnetic resonance imaging (MRI) were performed in patients with PM-ccRCC and pNET. Eleven patients with PM-ccRCC and 24 patients with pNET were enrolled into this retrospective study. The signal intensity was measured in the pancreatic tumor and spleen on in-phase and opposed-phase images. The signal intensity index (SII) and tumor-to-spleen ratio (TSR) in PM-ccRCC and pNET were calculated and compared. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic accuracy of SII and TSR in the differentiation between PM-ccRCC and pNET.

Results

The SII between PM-ccRCC and pNET (20.3% ± 16.8% vs. − 3.2% ± 11.4%) was significantly different (P < 0.001), as was the TSR (− 19.2% ± 16.6% vs. 6.0% ± 13.8%) (P < 0.001). The area under the ROC curve was 0.917 for the SII and 0.902 for the TSR. Additionally, an SII threshold value of 8.1% permitted the differentiation of PM-ccRCC from pNET with a sensitivity of 90.9%, a specificity of 91.7%, a positive predictive value of 90.1%, a negative predictive value of 91.7%, and an accuracy of 91.4%. A TSR cut-off value of − 4.7% enabled the differentiation of the two groups with a sensitivity of 79.2%, a specificity of 90.9%, a positive predictive value of 90.9%, a negative predictive value of 79.2% and an accuracy of 82.9%.

Conclusion

Double-echo GRE chemical shift MR imaging can accurately differentiate between PM-ccRCC and pNET.
Literature
7.
go back to reference Hijioka S, Hifumi M, Mekky MA, et al. (2010) Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Intern Med 49(6):557–562CrossRefPubMed Hijioka S, Hifumi M, Mekky MA, et al. (2010) Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Intern Med 49(6):557–562CrossRefPubMed
8.
go back to reference Thompson LD, Heffess CS (2000) Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 89(5):1076–1088CrossRefPubMed Thompson LD, Heffess CS (2000) Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 89(5):1076–1088CrossRefPubMed
25.
go back to reference Carucci LR, Siegelman ES, Feldman MD (1999) Pancreatic metastasis from clear cell renal carcinoma: diagnosis with chemical shift MRI. J Comput Assist Tomogr 23(6):934–936CrossRefPubMed Carucci LR, Siegelman ES, Feldman MD (1999) Pancreatic metastasis from clear cell renal carcinoma: diagnosis with chemical shift MRI. J Comput Assist Tomogr 23(6):934–936CrossRefPubMed
29.
go back to reference Wente MN, Kleeff J, Esposito I, et al. (2005) Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature. Pancreas 30(3):218–222CrossRefPubMed Wente MN, Kleeff J, Esposito I, et al. (2005) Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature. Pancreas 30(3):218–222CrossRefPubMed
34.
go back to reference Kassabian A, Stein J, Jabbour N, et al. (2000) Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology 56(2):211–215CrossRefPubMed Kassabian A, Stein J, Jabbour N, et al. (2000) Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology 56(2):211–215CrossRefPubMed
Metadata
Title
Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging
Authors
Hai-lian Lyu
Jian-xia Cao
Hai-yi Wang
Zhan-bo Wang
Ming-gen Hu
Lu Ma
Ying-wei Wang
Hui-yi Ye
Publication date
01-10-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1539-7

Other articles of this Issue 10/2018

Abdominal Radiology 10/2018 Go to the issue

Classics in Abdominal Radiology

The stack of coins sign in scleroderma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.